About Antares Pharma
Antares Pharma is a Healthcare company based in Ewing (United States) founded in 2000, and was acquired by Halozyme in April 2022. Existing drugs are reformulated using proprietary pen injectors. Antares Pharma offers products and services including ENHANZE, Auto-Injector, and Multi-Dose Pen. Its focus areas include Diversified Pharmaceuticals. Its legal entity is ANTARES PHARMA, INC.
Company details
Antares Pharma was established in 2000 in Ewing, United States, within the pharmaceuticals sector focused on drug delivery systems. Existing medications are reformulated through the VIBEX platform, featuring pre-filled pen injectors for intradermal, subcutaneous, or intramuscular administration. Collaborations are formed with pharmaceutical partners to adapt their products. The development pipeline encompasses injectors for human growth hormone from Ferring, estradiol from Meda, Gelnique from Actavis, and methotrexate.
- Headquarters Ewing, United States
- Stage Acquired
- SectorsHealthcare
- Website antarespharma.com
- Social LinkedIn X
- Acquired by Halozyme (Apr 2022)
- Legal Name Antares Pharma, Inc.
Products & Services of Antares Pharma
Antares Pharma offers a comprehensive portfolio of products and services, including ENHANZE, Auto-Injector, and Multi-Dose Pen.
Enhances drug administration for improved treatment efficacy.
Facilitates self-injection of medications for patient convenience.
Enables multiple doses in a single device for easier management.
Funding Insights of Antares Pharma
- Total Rounds 4
- Last Round Post-IPO — $2.75M
- First Round $5M
(Mar 2007)
- Investors Count 2
All 4 funding rounds of Antares Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2018 | $2.75M | Post-IPO | – | – | |
| Jun 2017 | $35M | Debt – Venture | – | – | |
| Jul 2007 | $16M | Debt – Venture | – | – | – |
| Mar 2007 | $5M | Debt – Conventional | – | – | – |
3 investors in total: 3 institutional.
Investors in Antares Pharma
Antares Pharma has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Halozyme, Hercules Capital and Ferring Pharmaceuticals.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture debt financing is provided to companies in multiple sectors. | 2003 | htgc.com | Palo Alto, United States | |
Provider of drugs in the areas of reproductive health, urology, gastroenterology, endocrinology and orthopaedics | 1950 | ferring.com | Saint Prex, Switzerland | |
Drug delivery technologies for disease treatment are developed. | 1999 | halozyme.com | San Diego, United States |
Investor details for Antares Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Antares Pharma
40 people are tracked at Antares Pharma (5 in leadership, 5 in board & advisors, 30 in team).
| Name | Role | Group |
|---|---|---|
Peter J. Graham | EVP, General Counsel, Human Resources, Chief Compliance Officer & Corporate Secretary | Leadership |
Robert F. Apple | President & CEO | Leadership |
Beth Sawyer | Director, National Accounts | Leadership |
Raymond G. Taylor | Senior Director Of Managed Care, Trade Relations & Government Pricing At Antares Pharma Inc. | Leadership |
Dan Kelsey | Vice President Sales And Marketing | Leadership |
Peter S. Greenleaf | Director | Board & advisors |
Thomas J. Garrity | Director | Board & advisors |
Robert P. Roche, Jr. | Director | Board & advisors |
Leonard S. Jacob | Chairman | Board & advisors |
Anton Gueth | Director | Board & advisors |
Marcel Nwulia | Speciality Account Representative | Team |
Peter Sadowski | SVP, Technology Portfolio & Intellectual Property | Team |
Michelle Sims | Clinical Specialist | Team |
Drew Hickey | Specialty Account Manager | Team |
Ed Tykot | SVP, Corporate Business Development | Team |
Carolyn Jackson | Specialty Account Representative | Team |
Sandra Cerovski | Sales Representative | Team |
Tom Swanson | Regional Account Specialist | Team |
Mallory Notermann | Senior Quality Assurance Specialist | Team |
Debra Schmeidler | Specialty Account Representative | Team |
20 more people are available in the full profile.
Complete people profiles for Antares Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Antares Pharma
5 dated milestones of Antares Pharma across 22 years, from founding to its latest funding, stage changes and deals.
- Founded Antares Pharma is founded.
- Funding First funding round of $5.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $2.8M.
- Exit Acquired by Halozyme.
Web traffic of Antares Pharma
Websites that share an audience with Antares Pharma (antarespharma.com).
Websites whose visitors overlap most with Antares Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| camb-labs.com | 100% | View details | |||
| vetter-pharma.com | 98% | 49K | #610,819 | View details | |
kurvetech.com | kurvetech.com | 97% | – | ||
directhaler.com | directhaler.com | 97% | – | ||
baxa.com | baxa.com | 97% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for Antares Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
3 companies that operate in the same segment as Antares Pharma (Pharmaceuticals & Distribution) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | USD 33.23 B | 28,000 | ||
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | USD 5.33 B | 55,000 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Antares Pharma
Complete news archive for Antares Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Antares Pharma
Antares Pharma was founded in 2000 and raised its 1st funding round 7 years after it was founded.
Antares Pharma is headquartered in Ewing, United States. It is registered at Ewing, New Jersey, United States.
Annual revenue of Antares Pharma is $183.98M as on Dec 31, 2021.
Antares Pharma was established in 2000 in Ewing, United States, within the pharmaceuticals sector focused on drug delivery systems. Existing medications are reformulated through the VIBEX platform, featuring pre-filled pen injectors for intradermal, subcutaneous, or intramuscular administration. Collaborations are formed with pharmaceutical partners to adapt their products. The development pipeline encompasses injectors for human growth hormone from Ferring, estradiol from Meda, Gelnique from Actavis, and methotrexate.
Antares Pharma offers ENHANZE, Auto-Injector, and Multi-Dose Pen.
Antares Pharma has 3 investors. Key investors include Halozyme, Hercules Capital, and Ferring Pharmaceuticals.
Antares Pharma operates through Antares Pharma, Inc..
Yes. Antares Pharma was acquired by Halozyme in April 2022.